Search research articles
Contact Us
Filters
Showing results (691-700 of 726) with videos related to
Page
of 73
Sort By:
Journal of the American Heart Association
|
November 16, 2022
Mean Coronary Cross-Sectional Area as a Measure of Arterial Remodeling Using Noncontrast CT Imaging in Persons With HIV
Ayoda T Werede, James G Terry, Sangeeta Nair, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 2, 2021
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia
Matthew C Cheung, Nicole Mittmann, Carolyn Owen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1997
Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group
K I Pritchard, A H Paterson, S Fine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2015
Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also
John M S Bartlett, Christopher C McConkey, Alison F Munro, et al.
International Journal of Epidemiology
|
November 14, 2012
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics
Margaret T May, Robert S Hogg, Amy C Justice, et al.
Journal of Clinical and Translational Science
|
November 30, 2023
Lessons learned from over a decade of data audits in international observational HIV cohorts in Latin America and East Africa
Sarah C Lotspeich, Bryan E Shepherd, Marion Achieng Kariuki, et al.
Kidney International
|
April 26, 2021
Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria
Usman J Wudil, Muktar H Aliyu, Heather L Prigmore, et al.
British Journal of Haematology
|
September 13, 2024
A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphoma
John Kuruvilla, Christopher Rushton, Diego Villa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2013
Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial
Paul E Goss, James N Ingle, Kathleen I Pritchard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2014
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12
Michael Crump, John Kuruvilla, Stephen Couban, et al.
Page
of 73
Search research articles
Search
Showing results (691-700 of 726) with videos related to
Sort By:
Page
of 73
Journal of the American Heart Association
|
November 16, 2022
Mean Coronary Cross-Sectional Area as a Measure of Arterial Remodeling Using Noncontrast CT Imaging in Persons With HIV
Ayoda T Werede, James G Terry, Sangeeta Nair, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 2, 2021
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia
Matthew C Cheung, Nicole Mittmann, Carolyn Owen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1997
Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group
K I Pritchard, A H Paterson, S Fine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 22, 2015
Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also
John M S Bartlett, Christopher C McConkey, Alison F Munro, et al.
International Journal of Epidemiology
|
November 14, 2012
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics
Margaret T May, Robert S Hogg, Amy C Justice, et al.
Journal of Clinical and Translational Science
|
November 30, 2023
Lessons learned from over a decade of data audits in international observational HIV cohorts in Latin America and East Africa
Sarah C Lotspeich, Bryan E Shepherd, Marion Achieng Kariuki, et al.
Kidney International
|
April 26, 2021
Apolipoprotein-1 risk variants and associated kidney phenotypes in an adult HIV cohort in Nigeria
Usman J Wudil, Muktar H Aliyu, Heather L Prigmore, et al.
British Journal of Haematology
|
September 13, 2024
A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphoma
John Kuruvilla, Christopher Rushton, Diego Villa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 30, 2013
Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial
Paul E Goss, James N Ingle, Kathleen I Pritchard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2014
Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12
Michael Crump, John Kuruvilla, Stephen Couban, et al.
Page
of 73